AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

AST SpaceMobile (NASDAQ: ASTS) stock jumped 7.6% through 11:15 a.m. ET Thursday after Cantor Fitzgerald analyst Colin ...

AstraZeneca cuts UK investment after government reduces site expansion support; Viking secures API supply; Jabil acquires ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

AstraZeneca has terminated all development of vemircopan, the oral factor D inhibitor it acquired through the deal for ...

SGA joins Wilt, Ant Edwards makes Wolves history, Darius Garland says goodnight, De'Aaron Fox shines in Spurs debut and more ...

--Best two-day stretch since the two days ending Nov. 11, 2020, when it rose 7.35% --Down 15.77% from its all-time closing high of $87.62 on Aug. 30, 2024 --Up 16.18% from 52 weeks ago (Feb. 8, 2024), ...

South Ripley's Cole Henry and Switzerland County's Cam Craig are the ORVC Boys Basketball Players of the Week. Henry broke ...

A senior director of satellite engineering at SpaceX raises doubts about AST SpaceMobile's satellite constellation and its ...

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...

Cantor Fitzgerald initiated coverage on AST Spacemobile (NASDAQ:ASTS) with an Overweight rating and a price target of $30.00. The stock, which has delivered an impressive return of over 750% in the ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super Bowl ...